TRYGAPOCE Trademark
Trademark Overview
On Monday, October 16, 2023, a trademark application was filed for TRYGAPOCE with the United States Patent and Trademark Office. The USPTO has given the TRYGAPOCE trademark a serial number of 98225245. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 10, 2024. This trademark is owned by Ionis Pharmaceuticals, Inc.. The TRYGAPOCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development in the field of genetic diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of genetic diseases and disorders; compiling data for research purposes in the field of genetic diseases and disorders; pharmaceutical research and development in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; compiling data for research purposes in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders
General Information
| Serial Number | 98225245 |
| Word Mark | TRYGAPOCE |
| Filing Date | Monday, October 16, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 16, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical research and development in the field of genetic diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of genetic diseases and disorders; compiling data for research purposes in the field of genetic diseases and disorders; pharmaceutical research and development in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; providing medical and scientific research and medical and scientific research information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; compiling data for research purposes in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 23, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ionis Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Carlsbad, CA 92010 |
| Party Name | Ionis Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Carlsbad, CA 92010 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 19, 2023 | NEW APPLICATION ENTERED |
| Sunday, June 2, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, October 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 26, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 10, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, September 25, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 25, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, September 25, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 25, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 25, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, September 25, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
